What is a notable side effect to monitor for when administering Imatinib?

Imatinib, a targeted therapy primarily used for certain types of leukemia and gastrointestinal tumors, is known to have specific side effects that healthcare professionals should monitor closely during treatment. The correct answer points to gastrointestinal upset and potential weight gain as notable side effects.

Gastrointestinal issues are quite common with Imatinib, with patients often experiencing symptoms like nausea, vomiting, diarrhea, or abdominal pain. These side effects can significantly impact the patient's quality of life and adherence to treatment. Weight gain can occur in some patients as a result of fluid retention, which may also be linked to gastrointestinal symptoms and dietary changes during therapy.

Overall, monitoring for GI upset is critical, as it helps in managing the patient's comfort, ensuring proper nutrition, and maintaining treatment compliance. This understanding allows practitioners to provide appropriate interventions to mitigate these side effects effectively.